KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Inventory: 2017-2025

Historic Change in Inventory for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $2.4 million.

  • Twist Bioscience's Change in Inventory rose 153.72% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 152.96%. This contributed to the annual value of $4.2 million for FY2025, which is 152.96% up from last year.
  • Latest data reveals that Twist Bioscience reported Change in Inventory of $2.4 million as of Q3 2025, which was down 53.37% from $5.1 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Change in Inventory ranged from a high of $10.6 million in Q3 2021 and a low of -$4.7 million during Q1 2023.
  • In the last 3 years, Twist Bioscience's Change in Inventory had a median value of -$1.9 million in 2024 and averaged -$1.5 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first spiked by 1,308.57% in 2021, then slumped by 446.71% in 2025.
  • Quarterly analysis of 5 years shows Twist Bioscience's Change in Inventory stood at $8.4 million in 2021, then crashed by 37.40% to $5.3 million in 2022, then crashed by 122.74% to -$1.2 million in 2023, then soared by 53.37% to -$560,000 in 2024, then surged by 153.72% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $5.1 million for Q2 2025, and -$2.7 million during Q1 2025.